Health Advance Inc Awarded Distributorship for Government Approved COVID Rapid Test
Health Advance Commercial Activity Picks Up PaceNEW YORK, NY / ACCESSWIRE / October 13, 2021 / Health Advance, Inc (OTC...
News
Black Duck Software Founder Joins Hyka Pre-Seed Round to Help Break Down the Barriers to Access Treatments at the Forefront of Psychiatry
BOSTON, MA / ACCESSWIRE / October 13, 2021 / Hyka, a healthtech start-up, announced today that prominent investor and entrepreneur,...
Novamind Granted DEA Licenses for Psilocybin Research
Licenses a key step in hosting contracted clinical trials for Schedule 1 controlled substancesTORONTO, ON / ACCESSWIRE / October 13,...
NanoViricides, Inc. Has Filed its Annual Report: Coronavirus Drug Program Rapidly Moving Towards Clinical Stage
SHELTON, CT / ACCESSWIRE / October 13, 2021 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), reports that it has filed...
HealthEquity Releases 15th Edition of HSA Guidebook to Commemorate HSA Awareness Day
Free, educational resource newly updated for open enrollmentDRAPER, Utah, Oct. 13, 2021 (GLOBE NEWSWIRE) -- HealthEquity (NASDAQ: HQY) is releasing...
Syapse Senior People Manager Recognized as 2021 WellBeyond Leader of the Year for Emerging Companies While the Company Takes Home Three Comparably Awards
Syapse has been recognized by its employees as a leader in company happiness, work-life balance, and perks and benefitsSAN FRANCISCO,...
CohBar Announces CB4211 Phase 1a/1b Results Selected for Late Breaker Presentation at The Liver Meeting® 2021
MENLO PARK, Calif., Oct. 13, 2021 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria...
Cosmetic Plastic Surgery Institute: Dr. Mowlavi Receives a Trademark for DrLaguna, Recognized for Exceptional Services to Cosmetic Plastic Surgery
Laguna Beach, CA, Oct. 13, 2021 (GLOBE NEWSWIRE) -- Across the globe, there are a tremendous amount of cosmetic plastic...
FDA Authorizes Sorrento Phase 2 Trial of Epidural Resiniferatoxin for the Orphan Indication of Control of Intractable Cancer Pain
Phase 2 trial of resiniferatoxin (RTX) to proceed following clearance from FDA.The decision is supported by the Phase 1 data...
Veru Enrolls First Patient in International Phase 3 ARTEST Clinical Trial of Enobosarm in Metastatic Breast Cancer
-- Enobosarm is a novel targeted hormone drug to be evaluated in the 3rd line treatment of androgen receptor positive...
SCYNEXIS to Present Pooled Data Analysis Results Demonstrating Consistent Efficacy and Safety Outcomes Across Two Phase 3 VANISH Clinical Trials of Oral Ibrexafungerp Therapy for Vaginal Yeast Infection at October Medical Conferences
JERSEY CITY, N.J., Oct. 13, 2021 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to...
Sharps Compliance Announces First Quarter Fiscal 2022 Conference Call and Webcast
HOUSTON, Oct. 13, 2021 (GLOBE NEWSWIRE) -- Sharps Compliance Corp. (NASDAQ: SMED) announced today that it will release its first...
InspireMD Receives Reimbursement Approval for CGuard™ Embolic Prevention System from the French National Authority for Health
TEL AVIV, Israel, Oct. 13, 2021 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), a global developer of the CGuard™ Embolic...
ICU Medical, Inc. Announces Time of Third Quarter 2021 Earnings Conference Call
SAN CLEMENTE, Calif., Oct. 13, 2021 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and...
Avricore Health Inc. (TSX.V: AVCR) (OTCQB: AVCRF) Wheelhouse at Center of Nascent Industry
NEW YORK, Oct. 13, 2021 (GLOBE NEWSWIRE) -- via InvestorWire — Avricore Health Inc. (TSX.V: AVCR) (OTCQB: AVCRF) today announces...
GBS Inc. Announces its Pre-Submission package is with the FDA
NEW YORK, Oct. 13, 2021 (GLOBE NEWSWIRE) -- GBS Inc. (Nasdaq: GBS), a life sciences company developing non-invasive, real-time diagnostic...
Rezolute Announces Pricing of Public Offering of $55 million of Common Stock and Pre-Funded Warrants, and Concurrent Registered Direct Offering
REDWOOD CITY, Calif., Oct. 13, 2021 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” or the “Company”), a clinical-stage biopharmaceutical...
Resverlogix to Present at Upcoming Conferences
Presentation Highlights will Include First-in-Class Epigenetic Small Molecule Candidate Apabetalone Being Evaluated as Potential Treatment for COVID-19CALGARY, Alberta, Oct. 13,...
New HBM+ report shares key insights on rapidly evolving drug landscape
TORONTO, Oct. 13, 2021 (GLOBE NEWSWIRE) -- With the COVID-19 pandemic fundamentally changing health care delivery across the country, a...
Selecta Biosciences to Present New Data for the ImmTOR™ platform at the ESGCT 28th Annual Congress
WATERTOWN, Mass., Oct. 13, 2021 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (NASDAQ: SELB), a biotechnology company leveraging its clinically validated...